Volume 17, Number 9—September 2011
Research
Seroepidemiologic Study of Pandemic (H1N1) 2009 during Outbreak in Boarding School, England
Sandra Johnson, Chikwe Ihekweazu
, Pia Hardelid, Nika Raphaely, Katja Hoschler, Alison Bermingham, Muhammad Abid, Richard Pebody, Graham Bickler, John Watson, and Éamonn O’Moore
, Pia Hardelid, Nika Raphaely, Katja Hoschler, Alison Bermingham, Muhammad Abid, Richard Pebody, Graham Bickler, John Watson, and Éamonn O’MooreTable 2
Association of demographic characteristics and interventions with study participants’ reports of ARI during outbreak of pandemic (H1N1) 2009 at a boarding school, England*
| Variable |
No. participants |
No. (%) with ARI |
Odds ratio (95% CI) |
|---|---|---|---|
| Total | 695 | 237 (34.1) | |
| Demographics | |||
| Category | |||
| Students | 469 | 187 (39.9) | 2.53 (1.75–3.65) |
| Staff | 226 | 50 (22.1) | 1 |
| Age group, y | |||
| 13–15 | 219 | 75 (34.2) | 1 |
| 16–18 | 250 | 112 (44.8) | 1.55 (1.06–2.28) |
| 20–49 | 111 | 32 (28.8) | 0.70 (0.42–1.15) |
| >50 | 87 | 18 (20.7) | 0.48 (0.26–0.86) |
| Sex, staff only† | |||
| F | 109 | 24 (22.0) | 1 |
| M | 117 | 26 (22.2) | 0.98 (0.52–1.83) |
| Role, staff only | |||
| Nonteaching | 135 | 26 (19.3) | 1 |
| Teaching |
85 |
23 (27.1) |
1.48 (0.78–2.82) |
| Interventions | |||
| Took antiviral drugs | |||
| No | 198 | 81 (40.9) | 1 |
| Yes | 393 | 110 (28.0) | 0.55 (0.38–0.79) |
| Use of antiviral drugs: PEP vs. treatment dose | |||
| No antiviral drugs | 198 | 81 (40.9) | 1 |
| Yes, PEP | 352 | 78 (22.2) | 0.40 (0.27–0.59) |
| Yes, treatment dose | 41 | 32 (78.1) | 4.87 (2.20–10.77) |
| Completion of PEP course of antiviral drugs† | |||
| No antiviral drugs | 198 | 81 (40.9) | 1 |
| Not completed | 51 | 14 (27.5) | 0.44 (0.17–1.15) |
| Completed | 294 | 62 (21.1) | 0.38 (0.22–0.65) |
| Seasonal Influenza vaccine | |||
| No | 216 | 66 (30.6) | 1 |
| Yes | 425 | 161 (37.9) | 1.35 (0.95–1.92) |
*Categories in which the response was missing or unknown are shown in the Table A1. ARI, acute respiratory infection; CI, confidence interval; PEP, postexposure prophylaxis.
†Excluding those who reported taking the treatment dose of antiviral drugs.
